Baolingbao Biology Co.,Ltd.

Equities

002286

CNE100000FL1

Food Processing

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
6.07 CNY +4.48% Intraday chart for Baolingbao Biology Co.,Ltd. +11.38% -25.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2023, Payable on 08 March 2024 CI
Baolingbao Biology Co.,Ltd. Proposes Cash Dividend for 2023 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Baolingbao Biology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2022, Payable on 20 June 2023 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Baolingbao Biology Plans $80 Million Forex Trading MT
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Baolingbao Biology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 27, 2022 CI
Baolingbao Biology Co.,Ltd. Announces Final Cash Dividend for the Year 2021 CI
Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Baolingbao Biology Co.,Ltd. announced that it expects to receive CNY 711.9 million in funding from Ganzhou Zhongke Yongyu Investment Management Center (Limited Partnership), Shenzhen Zhongke Yongyu Technology Partnership Enterprise (Limited Partnership), Beijing Yongyu Investment Management Co., Ltd. CI
Baolingbao Biology Co.,Ltd. Announces Cash Dividend of A Shares for the Year 2020, Payment Date on June 3, 2021 CI
Baolingbao Biology Co.,Ltd. Approves Cash Dividend for 2020 CI
Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020 CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections CI
Gao Yanming completed the acquisition of 6.8% in Baolingbao Biology Co.,Ltd. from Liu Zongli. CI
Chart Baolingbao Biology Co.,Ltd.
More charts
BAOLINGBAO BIOLOGY CO., LTD. is a China-based company principally engaged in the processing, manufacture and sale of sugar products. The Company mainly provides oligosaccharide series, sugar alcohol series, high fructose syrup series, other starch sugar series, as well as starch and byproducts. The Company distributes its products in domestic markets and to overseas markets.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002286 Stock
  4. News Baolingbao Biology Co.,Ltd.
  5. Baolingbao Biology Plans $80 Million Forex Trading